Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed.
Saved in:
| Title: | Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed. |
|---|---|
| Authors: | Ferrari S; Geneva University Hospital, Geneva, Switzerland. Electronic address: Serge.Ferrari@unige.ch., Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA., Butler PW; Amgen Inc., Thousand Oaks, CA, USA., Kendler DL; University of British Columbia, Vancouver, BC, Canada., Napoli N; Università Campus Bio-Medico di Roma, Roma, Italy; Division of Bone and Mineral Diseases, Washington University, St. Louis, MO, USA., Huang S; Amgen Inc., Thousand Oaks, CA, USA., Crittenden DB; Amgen Inc., Thousand Oaks, CA, USA., Pannacciulli N; Amgen Inc., Thousand Oaks, CA, USA., Siris E; Columbia University Medical Center, New York, NY, USA., Binkley N; University of Wisconsin-Madison, Madison, WI, USA. |
| Source: | Bone [Bone] 2020 May; Vol. 134, pp. 115287. Date of Electronic Publication: 2020 Feb 21. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
